Medipal Raises Year-End Dividend, Lifts Annual Payout to ¥66 Per Share

Medipal Holdings ( (JP:7459) ) has shared an update.

Medipal Holdings has announced an increase in its year-end dividend for the fiscal year ended March 31, 2026, raising the payout to ¥34 per share from the previously forecast ¥32, bringing total annual dividends to ¥66 per share including the already paid interim dividend of ¥32. The decision reflects management’s stated priority of shareholder returns and its policy to maintain or increase the dividend payout ratio while pursuing an optimal capital structure, suggesting continued emphasis on capital efficiency and potential for flexible share buybacks in response to funding needs and financial conditions.

Compared with the previous fiscal year’s total dividend of ¥62 per share, the latest move marks a further step-up in distributions and signals confidence in the company’s financial health. For investors, the higher dividend underscores Medipal’s commitment to enhanced shareholder value under its 2027 medium-term vision, reinforcing its positioning as a stable, income-generating stock within Japan’s healthcare distribution industry.

The most recent analyst rating on (JP:7459) stock is a Hold with a Yen2700.00 price target. To see the full list of analyst forecasts on Medipal Holdings stock, see the JP:7459 Stock Forecast page.

More about Medipal Holdings

Medipal Holdings Corporation is a Japan-based company listed on the Tokyo Stock Exchange Prime Market under code 7459. Operating in the healthcare and pharmaceutical distribution sector, it focuses on wholesale distribution of pharmaceuticals and related products, serving medical institutions, pharmacies, and other healthcare providers across Japan as a key player in the domestic medical supply chain.

Average Trading Volume: 417,105

Technical Sentiment Signal: Buy

Current Market Cap: Yen505.9B

Find detailed analytics on 7459 stock on TipRanks’ Stock Analysis page.